Trial Profile
A pharmacokinetic study evaluating drug interactions between boceprevir and ritonavir-boosted HIV protease inhibitors in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Feb 2013
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Atazanavir/ritonavir; Darunavir; Lopinavir/ritonavir; Ritonavir
- Indications Hepatitis C; HIV infections
- Focus Pharmacokinetics
- Sponsors Merck & Co
- 09 Mar 2012 The trial title is not an official title
- 06 Mar 2012 Results from this study were presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI), according to a Merck and Co. media release
- 06 Mar 2012 New trial record